163
Participants
Start Date
April 29, 2016
Primary Completion Date
October 18, 2017
Study Completion Date
October 18, 2017
AGN-199201 ophthalmic solution
1 drop of AGN-199201 ophthalmic solution Doses A, B, C in the eye.
AGN-190584 ophthalmic solution
1 drop AGN-190584 ophthalmic solution doses A, B and C in the eye.
AGN-190584 vehicle
Vehicle to AGN-190584
AGN-199201 + AGN-190584 Combination
1 drop AGN-199201 and AGN-190584 fixed combination ophthalmic solution in the eye.
AGN-199201 vehicle
Vehicle to AGN-199201
Scott & Christie and Associates, PC, Cranberry Township
Specialized Eye Care, Baltimore
Clayton Eye Center, Morrow
Mid Florida Eye Center, Mt. Dora
Total Eye Care, PA, Memphis
Cleveland Eye Clinic, Brecksville
Price Vision Group, Indianapolis
The Eye Centers of Racine & Kenosha, Kenosha
Comprehensive Eye Care, Ltd, Washington
Medical Center Ophthalmology Associates, San Antonio
Cataract and Glaucoma Center, El Paso
Corneal Consultants of Colorado, P.C., Littleton
Hoopes Durrie Rivera Research, LLC, Draper
Sall Research Medical Center, Artesia
Milton M. Hom, OD, FAAO, Azusa
West Coast Eye Care, San Diego
WCCT Global, LLC, Costa Mesa
The Eye Research Foundation, Newport Beach
North Bay Eye Associates, Inc., Petaluma
Martel Eye Medical Group, Rancho Cordova
Lead Sponsor
Allergan
INDUSTRY